BERTA CASAR

Dr. BERTA CASAR

Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Consejo, Superior de Investigaciones Científicas (CSIC)-Universidad de Cantabria, Santander, E-39011 Cantabria, Spain
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2008 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
Jose M Gonzalez-GranadoJose M Gonzalez-Granado
Jose M Gonzalez-Granado
ANAna Navarro-Puche
Ana Navarro-Puche
BERTA CASARBERTA CASAR
BERTA CASAR
Piero Crespo BarajaPiero Crespo Baraja
Piero Crespo Baraja
VAVicente Andrés
Vicente Andrés
Sequestration of c-Fos at the nuclear envelope (NE) through interaction with A-type lamins suppresses AP-1–dependent transcription. We show here that c-Fos accumulation within the extraction-resistant nuclear fraction (ERNF) and its interaction with lamin A are reduced and enhanced by gain-of and loss-of ERK1/2 activity, respectively. Moreover, hindering ERK1/2-dependent phosphorylation of c-Fos attenuates its release from the ERNF induced by serum and promotes its interaction with lamin A. Accordingly, serum stimulation rapidly releases preexisting c-Fos from the NE via ERK1/2-dependent phosphorylation, leading to a fast activation of AP-1 before de novo c-Fos synthesis. Moreover, lamin A–null cells exhibit increased AP-1 activity and reduced levels of c-Fos phosphorylation. We also find that active ERK1/2 interacts with lamin A and colocalizes with c-Fos and A-type lamins at the NE. Thus, NE-bound ERK1/2 functions as a molecular switch for rapid mitogen-dependent AP-1 activation through phosphorylation-induced release of preexisting c-Fos from its inhibitory interaction with lamin A/C.

1 August 2015 in Cancer Cell
Verified
Journal Article
Closed access
AHAna Herrero
Ana Herrero
APAdán Pinto
Adán Pinto
PCPaula Colón-Bolea
Paula Colón-Bolea
BERTA CASARBERTA CASAR
BERTA CASAR
MJMary Jones
Mary Jones
Piero Crespo BarajaPiero Crespo Baraja
Piero Crespo Baraja

1 September 2008 in Molecular Cell
Verified
Journal Article
Closed access
BERTA CASARBERTA CASAR
BERTA CASAR
APAdán Pinto
Adán Pinto
Piero Crespo BarajaPiero Crespo Baraja
Piero Crespo Baraja

3 December 2012 in Oncogene
Verified
Journal Article
Open access
PDF file
BERTA CASARBERTA CASAR
BERTA CASAR
IRI Rimann
I Rimann
HKH Kato
H Kato
SSS J Shattil
S J Shattil
JQJ P Quigley
J P Quigley
EDE I Deryugina
E I Deryugina
Specific cleavage of the transmembrane molecule, CUB domain-containing protein-1 (CDCP1), by plasmin-like serine proteases induces outside–in signal transduction that facilitates early stages of spontaneous metastasis leading to tumor cell intravasation, namely cell escape from the primary tumor, stromal invasion and transendothelial migration. We identified active β1 integrin as a biochemical and functional partner of the membrane-retained 70-kDa CDCP1 fragment, newly generated from its full-length 135-kDa precursor though proteolytic cleavage by serine proteases. Both in cell cultures and in live animals, active β1 integrin complexed preferentially with functionally activated, phosphorylated 70-kDa CDCP1. Complexing of β1 integrin the 70-kDa with CDCP1 fragment induced intracellular phosphorylation signaling, involving focal adhesion kinase-1 (FAK) and PI3 kinase (PI3K)-dependent Akt activation. Thus, inhibition of FAK/PI3K activities by specific inhibitors as well as short-hairpin RNA downregulation of β1 integrin significantly reduced FAK/Akt phosphorylation under conditions where CDCP1 was processed by serine proteases, indicating that FAK/PI3K/Akt pathway operates downstream of cleaved CDCP1 complexed with β1 integrin. Furthermore, this complex-dependent signaling correlated positively with high levels of tumor cell intravasation and dissemination. Correspondingly, abrogation in vivo of CDCP1 cleavage either by unique cleavage-blocking monoclonal antibody 10-D7 or by inhibition of proteolytic activity of plasmin-like serine proteases with aprotinin prevented β1 integrin/CDCP1 complexing and downstream FAK/Akt signaling concomitant with significant reduction of stromal invasion and spontaneous metastasis. Therefore, β1 integrin appears to serve as a motility-regulating partner mediating cross-talk between proteolytically cleaved, membrane-retained CDCP1 and members of FAK/PI3K/Akt pathway. This CDCP1 cleavage-induced signaling cascade constitutes a unique mechanism, independent of extracellular matrix remodeling, whereby a proteolytically cleaved CDCP1 regulates in vivo locomotion and metastasis of tumor cells through β1 integrin partnering. Our findings indicate that CDCP1 cleavage, occurring at the apex of a β1 integrin/FAK/PI3K/Akt signaling cascade, may represent a therapeutic target for CDCP1-positive cancers.

1 March 2009 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
BERTA CASARBERTA CASAR
BERTA CASAR
IAImanol Arozarena
Imanol Arozarena
VSVictoria Sanz-Moreno
Victoria Sanz-Moreno
APAdán Pinto
Adán Pinto
LALorena Agudo-Ibáñez
Lorena Agudo-Ibáñez
Piero Crespo BarajaPiero Crespo Baraja
Piero Crespo Baraja
Subcellular localization influences the nature of Ras/extracellular signal-regulated kinase (ERK) signals by unknown mechanisms. Herein, we demonstrate that the microenvironment from which Ras signals emanate determines which substrates will be preferentially phosphorylated by the activated ERK1/2. We show that the phosphorylation of epidermal growth factor receptor (EGFr) and cytosolic phospholipase A2 (cPLA2) is most prominent when ERK1/2 are activated from lipid rafts, whereas RSK1 is mainly activated by Ras signals from the disordered membrane. We present evidence indicating that the underlying mechanism of this substrate selectivity is governed by the participation of different scaffold proteins that distinctively couple ERK1/2, activated at defined microlocalizations, to specific substrates. As such, we show that for cPLA2 activation, ERK1/2 activated at lipid rafts interact with KSR1, whereas ERK1/2 activated at the endoplasmic reticulum utilize Sef-1. To phosphorylate the EGFr, ERK1/2 activated at lipid rafts require the participation of IQGAP1. Furthermore, we demonstrate that scaffold usage markedly influences the biological outcome of Ras site-specific signals. These results disclose an unprecedented spatial regulation of ERK1/2 substrate specificity, dictated by the microlocalization from which Ras signals originate and by the selection of specific scaffold proteins.

29 November 2010 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
JRJavier Rodríguez
Javier Rodríguez
FCFernando Calvo
Fernando Calvo
Jose M Gonzalez-GranadoJose M Gonzalez-Granado
Jose M Gonzalez-Granado
BERTA CASARBERTA CASAR
BERTA CASAR
VAVicente Andrés
Vicente Andrés
Piero Crespo BarajaPiero Crespo Baraja
Piero Crespo Baraja
As orchestrators of essential cellular processes like proliferation, ERK1/2 mitogen-activated protein kinase signals impact on cell cycle regulation. A-type lamins are major constituents of the nuclear matrix that also control the cell cycle machinery by largely unknown mechanisms. In this paper, we disclose a functional liaison between ERK1/2 and lamin A whereby cell cycle progression is regulated. We demonstrate that lamin A serves as a mutually exclusive dock for ERK1/2 and the retinoblastoma (Rb) protein. Our results reveal that, immediately after their postactivation entrance in the nucleus, ERK1/2 dislodge Rb from its interaction with lamin A, thereby facilitating its rapid phosphorylation and consequently promoting E2F activation and cell cycle entry. Interestingly, these effects are independent of ERK1/2 kinase activity. We also show that cellular transformation and tumor cell proliferation are dependent on the balance between lamin A and nuclear ERK1/2 levels, which determines Rb accessibility for phosphorylation/inactivation.